Global Preventive Vaccines Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect
The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Preventive Vaccines market covering all its essential aspects.
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Preventive Vaccines market are covered in Chapter 9:
Emergent BioSolutions Inc.
Merck & Co.
Moderna Inc.
Daiichi Sankyo Co. Ltd
Sanofi SA
Johnson & Johnson
Novavax, Inc.
GlaxoSmithKline plc
China National Biotec Group Company Ltd.
AstraZeneca plc
CSL Ltd.
Takeda Pharmaceutical Co. Ltd.
Bavarian Nordic A/S
Pfizer Inc.
In Chapter 5 and Chapter 7.3, based on types, the Preventive Vaccines market from 2017 to 2027 is primarily split into:
Live/Attenuated Vaccines
Inactivated Vaccines
Subunit Vaccines
Toxoid Vaccines
Conjugate Vaccines
Recombinant Vector Vaccines
Other Vaccines
In Chapter 6 and Chapter 7.4, based on applications, the Preventive Vaccines market from 2017 to 2027 covers:
Pneumococcal Disease
Poliovirus
Hepatitis
Influenza
Measles, Mumps, and Rubella (MMR)
Varicella
Human Papilloma Virus
COVID-19
Other Diseases
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Preventive Vaccines market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Preventive Vaccines Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Preventive Vaccines market are covered in Chapter 9:
Emergent BioSolutions Inc.
Merck & Co.
Moderna Inc.
Daiichi Sankyo Co. Ltd
Sanofi SA
Johnson & Johnson
Novavax, Inc.
GlaxoSmithKline plc
China National Biotec Group Company Ltd.
AstraZeneca plc
CSL Ltd.
Takeda Pharmaceutical Co. Ltd.
Bavarian Nordic A/S
Pfizer Inc.
In Chapter 5 and Chapter 7.3, based on types, the Preventive Vaccines market from 2017 to 2027 is primarily split into:
Live/Attenuated Vaccines
Inactivated Vaccines
Subunit Vaccines
Toxoid Vaccines
Conjugate Vaccines
Recombinant Vector Vaccines
Other Vaccines
In Chapter 6 and Chapter 7.4, based on applications, the Preventive Vaccines market from 2017 to 2027 covers:
Pneumococcal Disease
Poliovirus
Hepatitis
Influenza
Measles, Mumps, and Rubella (MMR)
Varicella
Human Papilloma Virus
COVID-19
Other Diseases
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Preventive Vaccines market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Preventive Vaccines Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
1 PREVENTIVE VACCINES MARKET OVERVIEW
1.1 Product Overview and Scope of Preventive Vaccines Market
1.2 Preventive Vaccines Market Segment by Type
1.2.1 Global Preventive Vaccines Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Preventive Vaccines Market Segment by Application
1.3.1 Preventive Vaccines Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Preventive Vaccines Market, Region Wise (2017-2027)
1.4.1 Global Preventive Vaccines Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Preventive Vaccines Market Status and Prospect (2017-2027)
1.4.3 Europe Preventive Vaccines Market Status and Prospect (2017-2027)
1.4.4 China Preventive Vaccines Market Status and Prospect (2017-2027)
1.4.5 Japan Preventive Vaccines Market Status and Prospect (2017-2027)
1.4.6 India Preventive Vaccines Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Preventive Vaccines Market Status and Prospect (2017-2027)
1.4.8 Latin America Preventive Vaccines Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Preventive Vaccines Market Status and Prospect (2017-2027)
1.5 Global Market Size of Preventive Vaccines (2017-2027)
1.5.1 Global Preventive Vaccines Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Preventive Vaccines Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Preventive Vaccines Market
2 INDUSTRY OUTLOOK
2.1 Preventive Vaccines Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Preventive Vaccines Market Drivers Analysis
2.4 Preventive Vaccines Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Preventive Vaccines Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Preventive Vaccines Industry Development
3 GLOBAL PREVENTIVE VACCINES MARKET LANDSCAPE BY PLAYER
3.1 Global Preventive Vaccines Sales Volume and Share by Player (2017-2022)
3.2 Global Preventive Vaccines Revenue and Market Share by Player (2017-2022)
3.3 Global Preventive Vaccines Average Price by Player (2017-2022)
3.4 Global Preventive Vaccines Gross Margin by Player (2017-2022)
3.5 Preventive Vaccines Market Competitive Situation and Trends
3.5.1 Preventive Vaccines Market Concentration Rate
3.5.2 Preventive Vaccines Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL PREVENTIVE VACCINES SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Preventive Vaccines Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Preventive Vaccines Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Preventive Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Preventive Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Preventive Vaccines Market Under COVID-19
4.5 Europe Preventive Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Preventive Vaccines Market Under COVID-19
4.6 China Preventive Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Preventive Vaccines Market Under COVID-19
4.7 Japan Preventive Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Preventive Vaccines Market Under COVID-19
4.8 India Preventive Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Preventive Vaccines Market Under COVID-19
4.9 Southeast Asia Preventive Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Preventive Vaccines Market Under COVID-19
4.10 Latin America Preventive Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Preventive Vaccines Market Under COVID-19
4.11 Middle East and Africa Preventive Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Preventive Vaccines Market Under COVID-19
5 GLOBAL PREVENTIVE VACCINES SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Preventive Vaccines Sales Volume and Market Share by Type (2017-2022)
5.2 Global Preventive Vaccines Revenue and Market Share by Type (2017-2022)
5.3 Global Preventive Vaccines Price by Type (2017-2022)
5.4 Global Preventive Vaccines Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Preventive Vaccines Sales Volume, Revenue and Growth Rate of Live/Attenuated Vaccines (2017-2022)
5.4.2 Global Preventive Vaccines Sales Volume, Revenue and Growth Rate of Inactivated Vaccines (2017-2022)
5.4.3 Global Preventive Vaccines Sales Volume, Revenue and Growth Rate of Subunit Vaccines (2017-2022)
5.4.4 Global Preventive Vaccines Sales Volume, Revenue and Growth Rate of Toxoid Vaccines (2017-2022)
5.4.5 Global Preventive Vaccines Sales Volume, Revenue and Growth Rate of Conjugate Vaccines (2017-2022)
5.4.6 Global Preventive Vaccines Sales Volume, Revenue and Growth Rate of Recombinant Vector Vaccines (2017-2022)
5.4.7 Global Preventive Vaccines Sales Volume, Revenue and Growth Rate of Other Vaccines (2017-2022)
6 GLOBAL PREVENTIVE VACCINES MARKET ANALYSIS BY APPLICATION
6.1 Global Preventive Vaccines Consumption and Market Share by Application (2017-2022)
6.2 Global Preventive Vaccines Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Preventive Vaccines Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Preventive Vaccines Consumption and Growth Rate of Pneumococcal Disease (2017-2022)
6.3.2 Global Preventive Vaccines Consumption and Growth Rate of Poliovirus (2017-2022)
6.3.3 Global Preventive Vaccines Consumption and Growth Rate of Hepatitis (2017-2022)
6.3.4 Global Preventive Vaccines Consumption and Growth Rate of Influenza (2017-2022)
6.3.5 Global Preventive Vaccines Consumption and Growth Rate of Measles, Mumps, and Rubella (MMR) (2017-2022)
6.3.6 Global Preventive Vaccines Consumption and Growth Rate of Varicella (2017-2022)
6.3.7 Global Preventive Vaccines Consumption and Growth Rate of Human Papilloma Virus (2017-2022)
6.3.8 Global Preventive Vaccines Consumption and Growth Rate of COVID-19 (2017-2022)
6.3.9 Global Preventive Vaccines Consumption and Growth Rate of Other Diseases (2017-2022)
7 GLOBAL PREVENTIVE VACCINES MARKET FORECAST (2022-2027)
7.1 Global Preventive Vaccines Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Preventive Vaccines Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Preventive Vaccines Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Preventive Vaccines Price and Trend Forecast (2022-2027)
7.2 Global Preventive Vaccines Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Preventive Vaccines Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Preventive Vaccines Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Preventive Vaccines Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Preventive Vaccines Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Preventive Vaccines Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Preventive Vaccines Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Preventive Vaccines Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Preventive Vaccines Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Preventive Vaccines Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Preventive Vaccines Revenue and Growth Rate of Live/Attenuated Vaccines (2022-2027)
7.3.2 Global Preventive Vaccines Revenue and Growth Rate of Inactivated Vaccines (2022-2027)
7.3.3 Global Preventive Vaccines Revenue and Growth Rate of Subunit Vaccines (2022-2027)
7.3.4 Global Preventive Vaccines Revenue and Growth Rate of Toxoid Vaccines (2022-2027)
7.3.5 Global Preventive Vaccines Revenue and Growth Rate of Conjugate Vaccines (2022-2027)
7.3.6 Global Preventive Vaccines Revenue and Growth Rate of Recombinant Vector Vaccines (2022-2027)
7.3.7 Global Preventive Vaccines Revenue and Growth Rate of Other Vaccines (2022-2027)
7.4 Global Preventive Vaccines Consumption Forecast by Application (2022-2027)
7.4.1 Global Preventive Vaccines Consumption Value and Growth Rate of Pneumococcal Disease(2022-2027)
7.4.2 Global Preventive Vaccines Consumption Value and Growth Rate of Poliovirus(2022-2027)
7.4.3 Global Preventive Vaccines Consumption Value and Growth Rate of Hepatitis(2022-2027)
7.4.4 Global Preventive Vaccines Consumption Value and Growth Rate of Influenza(2022-2027)
7.4.5 Global Preventive Vaccines Consumption Value and Growth Rate of Measles, Mumps, and Rubella (MMR)(2022-2027)
7.4.6 Global Preventive Vaccines Consumption Value and Growth Rate of Varicella(2022-2027)
7.4.7 Global Preventive Vaccines Consumption Value and Growth Rate of Human Papilloma Virus(2022-2027)
7.4.8 Global Preventive Vaccines Consumption Value and Growth Rate of COVID-19(2022-2027)
7.4.9 Global Preventive Vaccines Consumption Value and Growth Rate of Other Diseases(2022-2027)
7.5 Preventive Vaccines Market Forecast Under COVID-19
8 PREVENTIVE VACCINES MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Preventive Vaccines Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Preventive Vaccines Analysis
8.6 Major Downstream Buyers of Preventive Vaccines Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Preventive Vaccines Industry
9 PLAYERS PROFILES
9.1 Emergent BioSolutions Inc.
9.1.1 Emergent BioSolutions Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Preventive Vaccines Product Profiles, Application and Specification
9.1.3 Emergent BioSolutions Inc. Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Merck & Co.
9.2.1 Merck & Co. Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Preventive Vaccines Product Profiles, Application and Specification
9.2.3 Merck & Co. Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Moderna Inc.
9.3.1 Moderna Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Preventive Vaccines Product Profiles, Application and Specification
9.3.3 Moderna Inc. Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Daiichi Sankyo Co. Ltd
9.4.1 Daiichi Sankyo Co. Ltd Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Preventive Vaccines Product Profiles, Application and Specification
9.4.3 Daiichi Sankyo Co. Ltd Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 Sanofi SA
9.5.1 Sanofi SA Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Preventive Vaccines Product Profiles, Application and Specification
9.5.3 Sanofi SA Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Johnson & Johnson
9.6.1 Johnson & Johnson Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Preventive Vaccines Product Profiles, Application and Specification
9.6.3 Johnson & Johnson Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Novavax, Inc.
9.7.1 Novavax, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Preventive Vaccines Product Profiles, Application and Specification
9.7.3 Novavax, Inc. Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 GlaxoSmithKline plc
9.8.1 GlaxoSmithKline plc Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Preventive Vaccines Product Profiles, Application and Specification
9.8.3 GlaxoSmithKline plc Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 China National Biotec Group Company Ltd.
9.9.1 China National Biotec Group Company Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Preventive Vaccines Product Profiles, Application and Specification
9.9.3 China National Biotec Group Company Ltd. Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 AstraZeneca plc
9.10.1 AstraZeneca plc Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Preventive Vaccines Product Profiles, Application and Specification
9.10.3 AstraZeneca plc Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
9.11 CSL Ltd.
9.11.1 CSL Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 Preventive Vaccines Product Profiles, Application and Specification
9.11.3 CSL Ltd. Market Performance (2017-2022)
9.11.4 Recent Development
9.11.5 SWOT Analysis
9.12 Takeda Pharmaceutical Co. Ltd.
9.12.1 Takeda Pharmaceutical Co. Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
9.12.2 Preventive Vaccines Product Profiles, Application and Specification
9.12.3 Takeda Pharmaceutical Co. Ltd. Market Performance (2017-2022)
9.12.4 Recent Development
9.12.5 SWOT Analysis
9.13 Bavarian Nordic A/S
9.13.1 Bavarian Nordic A/S Basic Information, Manufacturing Base, Sales Region and Competitors
9.13.2 Preventive Vaccines Product Profiles, Application and Specification
9.13.3 Bavarian Nordic A/S Market Performance (2017-2022)
9.13.4 Recent Development
9.13.5 SWOT Analysis
9.14 Pfizer Inc.
9.14.1 Pfizer Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.14.2 Preventive Vaccines Product Profiles, Application and Specification
9.14.3 Pfizer Inc. Market Performance (2017-2022)
9.14.4 Recent Development
9.14.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
1.1 Product Overview and Scope of Preventive Vaccines Market
1.2 Preventive Vaccines Market Segment by Type
1.2.1 Global Preventive Vaccines Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Preventive Vaccines Market Segment by Application
1.3.1 Preventive Vaccines Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Preventive Vaccines Market, Region Wise (2017-2027)
1.4.1 Global Preventive Vaccines Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Preventive Vaccines Market Status and Prospect (2017-2027)
1.4.3 Europe Preventive Vaccines Market Status and Prospect (2017-2027)
1.4.4 China Preventive Vaccines Market Status and Prospect (2017-2027)
1.4.5 Japan Preventive Vaccines Market Status and Prospect (2017-2027)
1.4.6 India Preventive Vaccines Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Preventive Vaccines Market Status and Prospect (2017-2027)
1.4.8 Latin America Preventive Vaccines Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Preventive Vaccines Market Status and Prospect (2017-2027)
1.5 Global Market Size of Preventive Vaccines (2017-2027)
1.5.1 Global Preventive Vaccines Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Preventive Vaccines Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Preventive Vaccines Market
2 INDUSTRY OUTLOOK
2.1 Preventive Vaccines Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Preventive Vaccines Market Drivers Analysis
2.4 Preventive Vaccines Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Preventive Vaccines Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Preventive Vaccines Industry Development
3 GLOBAL PREVENTIVE VACCINES MARKET LANDSCAPE BY PLAYER
3.1 Global Preventive Vaccines Sales Volume and Share by Player (2017-2022)
3.2 Global Preventive Vaccines Revenue and Market Share by Player (2017-2022)
3.3 Global Preventive Vaccines Average Price by Player (2017-2022)
3.4 Global Preventive Vaccines Gross Margin by Player (2017-2022)
3.5 Preventive Vaccines Market Competitive Situation and Trends
3.5.1 Preventive Vaccines Market Concentration Rate
3.5.2 Preventive Vaccines Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL PREVENTIVE VACCINES SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Preventive Vaccines Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Preventive Vaccines Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Preventive Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Preventive Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Preventive Vaccines Market Under COVID-19
4.5 Europe Preventive Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Preventive Vaccines Market Under COVID-19
4.6 China Preventive Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Preventive Vaccines Market Under COVID-19
4.7 Japan Preventive Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Preventive Vaccines Market Under COVID-19
4.8 India Preventive Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Preventive Vaccines Market Under COVID-19
4.9 Southeast Asia Preventive Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Preventive Vaccines Market Under COVID-19
4.10 Latin America Preventive Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Preventive Vaccines Market Under COVID-19
4.11 Middle East and Africa Preventive Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Preventive Vaccines Market Under COVID-19
5 GLOBAL PREVENTIVE VACCINES SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Preventive Vaccines Sales Volume and Market Share by Type (2017-2022)
5.2 Global Preventive Vaccines Revenue and Market Share by Type (2017-2022)
5.3 Global Preventive Vaccines Price by Type (2017-2022)
5.4 Global Preventive Vaccines Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Preventive Vaccines Sales Volume, Revenue and Growth Rate of Live/Attenuated Vaccines (2017-2022)
5.4.2 Global Preventive Vaccines Sales Volume, Revenue and Growth Rate of Inactivated Vaccines (2017-2022)
5.4.3 Global Preventive Vaccines Sales Volume, Revenue and Growth Rate of Subunit Vaccines (2017-2022)
5.4.4 Global Preventive Vaccines Sales Volume, Revenue and Growth Rate of Toxoid Vaccines (2017-2022)
5.4.5 Global Preventive Vaccines Sales Volume, Revenue and Growth Rate of Conjugate Vaccines (2017-2022)
5.4.6 Global Preventive Vaccines Sales Volume, Revenue and Growth Rate of Recombinant Vector Vaccines (2017-2022)
5.4.7 Global Preventive Vaccines Sales Volume, Revenue and Growth Rate of Other Vaccines (2017-2022)
6 GLOBAL PREVENTIVE VACCINES MARKET ANALYSIS BY APPLICATION
6.1 Global Preventive Vaccines Consumption and Market Share by Application (2017-2022)
6.2 Global Preventive Vaccines Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Preventive Vaccines Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Preventive Vaccines Consumption and Growth Rate of Pneumococcal Disease (2017-2022)
6.3.2 Global Preventive Vaccines Consumption and Growth Rate of Poliovirus (2017-2022)
6.3.3 Global Preventive Vaccines Consumption and Growth Rate of Hepatitis (2017-2022)
6.3.4 Global Preventive Vaccines Consumption and Growth Rate of Influenza (2017-2022)
6.3.5 Global Preventive Vaccines Consumption and Growth Rate of Measles, Mumps, and Rubella (MMR) (2017-2022)
6.3.6 Global Preventive Vaccines Consumption and Growth Rate of Varicella (2017-2022)
6.3.7 Global Preventive Vaccines Consumption and Growth Rate of Human Papilloma Virus (2017-2022)
6.3.8 Global Preventive Vaccines Consumption and Growth Rate of COVID-19 (2017-2022)
6.3.9 Global Preventive Vaccines Consumption and Growth Rate of Other Diseases (2017-2022)
7 GLOBAL PREVENTIVE VACCINES MARKET FORECAST (2022-2027)
7.1 Global Preventive Vaccines Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Preventive Vaccines Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Preventive Vaccines Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Preventive Vaccines Price and Trend Forecast (2022-2027)
7.2 Global Preventive Vaccines Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Preventive Vaccines Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Preventive Vaccines Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Preventive Vaccines Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Preventive Vaccines Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Preventive Vaccines Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Preventive Vaccines Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Preventive Vaccines Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Preventive Vaccines Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Preventive Vaccines Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Preventive Vaccines Revenue and Growth Rate of Live/Attenuated Vaccines (2022-2027)
7.3.2 Global Preventive Vaccines Revenue and Growth Rate of Inactivated Vaccines (2022-2027)
7.3.3 Global Preventive Vaccines Revenue and Growth Rate of Subunit Vaccines (2022-2027)
7.3.4 Global Preventive Vaccines Revenue and Growth Rate of Toxoid Vaccines (2022-2027)
7.3.5 Global Preventive Vaccines Revenue and Growth Rate of Conjugate Vaccines (2022-2027)
7.3.6 Global Preventive Vaccines Revenue and Growth Rate of Recombinant Vector Vaccines (2022-2027)
7.3.7 Global Preventive Vaccines Revenue and Growth Rate of Other Vaccines (2022-2027)
7.4 Global Preventive Vaccines Consumption Forecast by Application (2022-2027)
7.4.1 Global Preventive Vaccines Consumption Value and Growth Rate of Pneumococcal Disease(2022-2027)
7.4.2 Global Preventive Vaccines Consumption Value and Growth Rate of Poliovirus(2022-2027)
7.4.3 Global Preventive Vaccines Consumption Value and Growth Rate of Hepatitis(2022-2027)
7.4.4 Global Preventive Vaccines Consumption Value and Growth Rate of Influenza(2022-2027)
7.4.5 Global Preventive Vaccines Consumption Value and Growth Rate of Measles, Mumps, and Rubella (MMR)(2022-2027)
7.4.6 Global Preventive Vaccines Consumption Value and Growth Rate of Varicella(2022-2027)
7.4.7 Global Preventive Vaccines Consumption Value and Growth Rate of Human Papilloma Virus(2022-2027)
7.4.8 Global Preventive Vaccines Consumption Value and Growth Rate of COVID-19(2022-2027)
7.4.9 Global Preventive Vaccines Consumption Value and Growth Rate of Other Diseases(2022-2027)
7.5 Preventive Vaccines Market Forecast Under COVID-19
8 PREVENTIVE VACCINES MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Preventive Vaccines Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Preventive Vaccines Analysis
8.6 Major Downstream Buyers of Preventive Vaccines Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Preventive Vaccines Industry
9 PLAYERS PROFILES
9.1 Emergent BioSolutions Inc.
9.1.1 Emergent BioSolutions Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Preventive Vaccines Product Profiles, Application and Specification
9.1.3 Emergent BioSolutions Inc. Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Merck & Co.
9.2.1 Merck & Co. Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Preventive Vaccines Product Profiles, Application and Specification
9.2.3 Merck & Co. Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Moderna Inc.
9.3.1 Moderna Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Preventive Vaccines Product Profiles, Application and Specification
9.3.3 Moderna Inc. Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Daiichi Sankyo Co. Ltd
9.4.1 Daiichi Sankyo Co. Ltd Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Preventive Vaccines Product Profiles, Application and Specification
9.4.3 Daiichi Sankyo Co. Ltd Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 Sanofi SA
9.5.1 Sanofi SA Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Preventive Vaccines Product Profiles, Application and Specification
9.5.3 Sanofi SA Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Johnson & Johnson
9.6.1 Johnson & Johnson Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Preventive Vaccines Product Profiles, Application and Specification
9.6.3 Johnson & Johnson Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Novavax, Inc.
9.7.1 Novavax, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Preventive Vaccines Product Profiles, Application and Specification
9.7.3 Novavax, Inc. Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 GlaxoSmithKline plc
9.8.1 GlaxoSmithKline plc Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Preventive Vaccines Product Profiles, Application and Specification
9.8.3 GlaxoSmithKline plc Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 China National Biotec Group Company Ltd.
9.9.1 China National Biotec Group Company Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Preventive Vaccines Product Profiles, Application and Specification
9.9.3 China National Biotec Group Company Ltd. Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 AstraZeneca plc
9.10.1 AstraZeneca plc Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Preventive Vaccines Product Profiles, Application and Specification
9.10.3 AstraZeneca plc Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
9.11 CSL Ltd.
9.11.1 CSL Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 Preventive Vaccines Product Profiles, Application and Specification
9.11.3 CSL Ltd. Market Performance (2017-2022)
9.11.4 Recent Development
9.11.5 SWOT Analysis
9.12 Takeda Pharmaceutical Co. Ltd.
9.12.1 Takeda Pharmaceutical Co. Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
9.12.2 Preventive Vaccines Product Profiles, Application and Specification
9.12.3 Takeda Pharmaceutical Co. Ltd. Market Performance (2017-2022)
9.12.4 Recent Development
9.12.5 SWOT Analysis
9.13 Bavarian Nordic A/S
9.13.1 Bavarian Nordic A/S Basic Information, Manufacturing Base, Sales Region and Competitors
9.13.2 Preventive Vaccines Product Profiles, Application and Specification
9.13.3 Bavarian Nordic A/S Market Performance (2017-2022)
9.13.4 Recent Development
9.13.5 SWOT Analysis
9.14 Pfizer Inc.
9.14.1 Pfizer Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.14.2 Preventive Vaccines Product Profiles, Application and Specification
9.14.3 Pfizer Inc. Market Performance (2017-2022)
9.14.4 Recent Development
9.14.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
LIST OF TABLES AND FIGURES
Figure Preventive Vaccines Product Picture
Table Global Preventive Vaccines Market Sales Volume and CAGR (%) Comparison by Type
Table Preventive Vaccines Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Preventive Vaccines Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Preventive Vaccines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Preventive Vaccines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Preventive Vaccines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Preventive Vaccines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Preventive Vaccines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Preventive Vaccines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Preventive Vaccines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Preventive Vaccines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Preventive Vaccines Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Preventive Vaccines Industry Development
Table Global Preventive Vaccines Sales Volume by Player (2017-2022)
Table Global Preventive Vaccines Sales Volume Share by Player (2017-2022)
Figure Global Preventive Vaccines Sales Volume Share by Player in 2021
Table Preventive Vaccines Revenue (Million USD) by Player (2017-2022)
Table Preventive Vaccines Revenue Market Share by Player (2017-2022)
Table Preventive Vaccines Price by Player (2017-2022)
Table Preventive Vaccines Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Preventive Vaccines Sales Volume, Region Wise (2017-2022)
Table Global Preventive Vaccines Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Preventive Vaccines Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Preventive Vaccines Sales Volume Market Share, Region Wise in 2021
Table Global Preventive Vaccines Revenue (Million USD), Region Wise (2017-2022)
Table Global Preventive Vaccines Revenue Market Share, Region Wise (2017-2022)
Figure Global Preventive Vaccines Revenue Market Share, Region Wise (2017-2022)
Figure Global Preventive Vaccines Revenue Market Share, Region Wise in 2021
Table Global Preventive Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Preventive Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Preventive Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Preventive Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Preventive Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Preventive Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Preventive Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Preventive Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Preventive Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Preventive Vaccines Sales Volume by Type (2017-2022)
Table Global Preventive Vaccines Sales Volume Market Share by Type (2017-2022)
Figure Global Preventive Vaccines Sales Volume Market Share by Type in 2021
Table Global Preventive Vaccines Revenue (Million USD) by Type (2017-2022)
Table Global Preventive Vaccines Revenue Market Share by Type (2017-2022)
Figure Global Preventive Vaccines Revenue Market Share by Type in 2021
Table Preventive Vaccines Price by Type (2017-2022)
Figure Global Preventive Vaccines Sales Volume and Growth Rate of Live/Attenuated Vaccines (2017-2022)
Figure Global Preventive Vaccines Revenue (Million USD) and Growth Rate of Live/Attenuated Vaccines (2017-2022)
Figure Global Preventive Vaccines Sales Volume and Growth Rate of Inactivated Vaccines (2017-2022)
Figure Global Preventive Vaccines Revenue (Million USD) and Growth Rate of Inactivated Vaccines (2017-2022)
Figure Global Preventive Vaccines Sales Volume and Growth Rate of Subunit Vaccines (2017-2022)
Figure Global Preventive Vaccines Revenue (Million USD) and Growth Rate of Subunit Vaccines (2017-2022)
Figure Global Preventive Vaccines Sales Volume and Growth Rate of Toxoid Vaccines (2017-2022)
Figure Global Preventive Vaccines Revenue (Million USD) and Growth Rate of Toxoid Vaccines (2017-2022)
Figure Global Preventive Vaccines Sales Volume and Growth Rate of Conjugate Vaccines (2017-2022)
Figure Global Preventive Vaccines Revenue (Million USD) and Growth Rate of Conjugate Vaccines (2017-2022)
Figure Global Preventive Vaccines Sales Volume and Growth Rate of Recombinant Vector Vaccines (2017-2022)
Figure Global Preventive Vaccines Revenue (Million USD) and Growth Rate of Recombinant Vector Vaccines (2017-2022)
Figure Global Preventive Vaccines Sales Volume and Growth Rate of Other Vaccines (2017-2022)
Figure Global Preventive Vaccines Revenue (Million USD) and Growth Rate of Other Vaccines (2017-2022)
Table Global Preventive Vaccines Consumption by Application (2017-2022)
Table Global Preventive Vaccines Consumption Market Share by Application (2017-2022)
Table Global Preventive Vaccines Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Preventive Vaccines Consumption Revenue Market Share by Application (2017-2022)
Table Global Preventive Vaccines Consumption and Growth Rate of Pneumococcal Disease (2017-2022)
Table Global Preventive Vaccines Consumption and Growth Rate of Poliovirus (2017-2022)
Table Global Preventive Vaccines Consumption and Growth Rate of Hepatitis (2017-2022)
Table Global Preventive Vaccines Consumption and Growth Rate of Influenza (2017-2022)
Table Global Preventive Vaccines Consumption and Growth Rate of Measles, Mumps, and Rubella (MMR) (2017-2022)
Table Global Preventive Vaccines Consumption and Growth Rate of Varicella (2017-2022)
Table Global Preventive Vaccines Consumption and Growth Rate of Human Papilloma Virus (2017-2022)
Table Global Preventive Vaccines Consumption and Growth Rate of COVID-19 (2017-2022)
Table Global Preventive Vaccines Consumption and Growth Rate of Other Diseases (2017-2022)
Figure Global Preventive Vaccines Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Preventive Vaccines Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Preventive Vaccines Price and Trend Forecast (2022-2027)
Figure USA Preventive Vaccines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Preventive Vaccines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Preventive Vaccines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Preventive Vaccines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Preventive Vaccines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Preventive Vaccines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Preventive Vaccines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Preventive Vaccines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Preventive Vaccines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Preventive Vaccines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Preventive Vaccines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Preventive Vaccines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Preventive Vaccines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Preventive Vaccines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Preventive Vaccines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Preventive Vaccines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Preventive Vaccines Market Sales Volume Forecast, by Type
Table Global Preventive Vaccines Sales Volume Market Share Forecast, by Type
Table Global Preventive Vaccines Market Revenue (Million USD) Forecast, by Type
Table Global Preventive Vaccines Revenue Market Share Forecast, by Type
Table Global Preventive Vaccines Price Forecast, by Type
Figure Global Preventive Vaccines Revenue (Million USD) and Growth Rate of Live/Attenuated Vaccines (2022-2027)
Figure Global Preventive Vaccines Revenue (Million USD) and Growth Rate of Live/Attenuated Vaccines (2022-2027)
Figure Global Preventive Vaccines Revenue (Million USD) and Growth Rate of Inactivated Vaccines (2022-2027)
Figure Global Preventive Vaccines Revenue (Million USD) and Growth Rate of Inactivated Vaccines (2022-2027)
Figure Global Preventive Vaccines Revenue (Million USD) and Growth Rate of Subunit Vaccines (2022-2027)
Figure Global Preventive Vaccines Revenue (Million USD) and Growth Rate of Subunit Vaccines (2022-2027)
Figure Global Preventive Vaccines Revenue (Million USD) and Growth Rate of Toxoid Vaccines (2022-2027)
Figure Global Preventive Vaccines Revenue (Million USD) and Growth Rate of Toxoid Vaccines (2022-2027)
Figure Global Preventive Vaccines Revenue (Million USD) and Growth Rate of Conjugate Vaccines (2022-2027)
Figure Global Preventive Vaccines Revenue (Million USD) and Growth Rate of Conjugate Vaccines (2022-2027)
Figure Global Preventive Vaccines Revenue (Million USD) and Growth Rate of Recombinant Vector Vaccines (2022-2027)
Figure Global Preventive Vaccines Revenue (Million USD) and Growth Rate of Recombinant Vector Vaccines (2022-2027)
Figure Global Preventive Vaccines Revenue (Million USD) and Growth Rate of Other Vaccines (2022-2027)
Figure Global Preventive Vaccines Revenue (Million USD) and Growth Rate of Other Vaccines (2022-2027)
Table Global Preventive Vaccines Market Consumption Forecast, by Application
Table Global Preventive Vaccines Consumption Market Share Forecast, by Application
Table Global Preventive Vaccines Market Revenue (Million USD) Forecast, by Application
Table Global Preventive Vaccines Revenue Market Share Forecast, by Application
Figure Global Preventive Vaccines Consumption Value (Million USD) and Growth Rate of Pneumococcal Disease (2022-2027)
Figure Global Preventive Vaccines Consumption Value (Million USD) and Growth Rate of Poliovirus (2022-2027)
Figure Global Preventive Vaccines Consumption Value (Million USD) and Growth Rate of Hepatitis (2022-2027)
Figure Global Preventive Vaccines Consumption Value (Million USD) and Growth Rate of Influenza (2022-2027)
Figure Global Preventive Vaccines Consumption Value (Million USD) and Growth Rate of Measles, Mumps, and Rubella (MMR) (2022-2027)
Figure Global Preventive Vaccines Consumption Value (Million USD) and Growth Rate of Varicella (2022-2027)
Figure Global Preventive Vaccines Consumption Value (Million USD) and Growth Rate of Human Papilloma Virus (2022-2027)
Figure Global Preventive Vaccines Consumption Value (Million USD) and Growth Rate of COVID-19 (2022-2027)
Figure Global Preventive Vaccines Consumption Value (Million USD) and Growth Rate of Other Diseases (2022-2027)
Figure Preventive Vaccines Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Emergent BioSolutions Inc. Profile
Table Emergent BioSolutions Inc. Preventive Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Emergent BioSolutions Inc. Preventive Vaccines Sales Volume and Growth Rate
Figure Emergent BioSolutions Inc. Revenue (Million USD) Market Share 2017-2022
Table Merck & Co. Profile
Table Merck & Co. Preventive Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Merck & Co. Preventive Vaccines Sales Volume and Growth Rate
Figure Merck & Co. Revenue (Million USD) Market Share 2017-2022
Table Moderna Inc. Profile
Table Moderna Inc. Preventive Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Moderna Inc. Preventive Vaccines Sales Volume and Growth Rate
Figure Moderna Inc. Revenue (Million USD) Market Share 2017-2022
Table Daiichi Sankyo Co. Ltd Profile
Table Daiichi Sankyo Co. Ltd Preventive Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Daiichi Sankyo Co. Ltd Preventive Vaccines Sales Volume and Growth Rate
Figure Daiichi Sankyo Co. Ltd Revenue (Million USD) Market Share 2017-2022
Table Sanofi SA Profile
Table Sanofi SA Preventive Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Sanofi SA Preventive Vaccines Sales Volume and Growth Rate
Figure Sanofi SA Revenue (Million USD) Market Share 2017-2022
Table Johnson & Johnson Profile
Table Johnson & Johnson Preventive Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Johnson & Johnson Preventive Vaccines Sales Volume and Growth Rate
Figure Johnson & Johnson Revenue (Million USD) Market Share 2017-2022
Table Novavax, Inc. Profile
Table Novavax, Inc. Preventive Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Novavax, Inc. Preventive Vaccines Sales Volume and Growth Rate
Figure Novavax, Inc. Revenue (Million USD) Market Share 2017-2022
Table GlaxoSmithKline plc Profile
Table GlaxoSmithKline plc Preventive Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure GlaxoSmithKline plc Preventive Vaccines Sales Volume and Growth Rate
Figure GlaxoSmithKline plc Revenue (Million USD) Market Share 2017-2022
Table China National Biotec Group Company Ltd. Profile
Table China National Biotec Group Company Ltd. Preventive Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure China National Biotec Group Company Ltd. Preventive Vaccines Sales Volume and Growth Rate
Figure China National Biotec Group Company Ltd. Revenue (Million USD) Market Share 2017-2022
Table AstraZeneca plc Profile
Table AstraZeneca plc Preventive Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure AstraZeneca plc Preventive Vaccines Sales Volume and Growth Rate
Figure AstraZeneca plc Revenue (Million USD) Market Share 2017-2022
Table CSL Ltd. Profile
Table CSL Ltd. Preventive Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure CSL Ltd. Preventive Vaccines Sales Volume and Growth Rate
Figure CSL Ltd. Revenue (Million USD) Market Share 2017-2022
Table Takeda Pharmaceutical Co. Ltd. Profile
Table Takeda Pharmaceutical Co. Ltd. Preventive Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Takeda Pharmaceutical Co. Ltd. Preventive Vaccines Sales Volume and Growth Rate
Figure Takeda Pharmaceutical Co. Ltd. Revenue (Million USD) Market Share 2017-2022
Table Bavarian Nordic A/S Profile
Table Bavarian Nordic A/S Preventive Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Bavarian Nordic A/S Preventive Vaccines Sales Volume and Growth Rate
Figure Bavarian Nordic A/S Revenue (Million USD) Market Share 2017-2022
Table Pfizer Inc. Profile
Table Pfizer Inc. Preventive Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pfizer Inc. Preventive Vaccines Sales Volume and Growth Rate
Figure Pfizer Inc. Revenue (Million USD) Market Share 2017-2022
Figure Preventive Vaccines Product Picture
Table Global Preventive Vaccines Market Sales Volume and CAGR (%) Comparison by Type
Table Preventive Vaccines Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Preventive Vaccines Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Preventive Vaccines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Preventive Vaccines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Preventive Vaccines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Preventive Vaccines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Preventive Vaccines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Preventive Vaccines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Preventive Vaccines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Preventive Vaccines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Preventive Vaccines Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Preventive Vaccines Industry Development
Table Global Preventive Vaccines Sales Volume by Player (2017-2022)
Table Global Preventive Vaccines Sales Volume Share by Player (2017-2022)
Figure Global Preventive Vaccines Sales Volume Share by Player in 2021
Table Preventive Vaccines Revenue (Million USD) by Player (2017-2022)
Table Preventive Vaccines Revenue Market Share by Player (2017-2022)
Table Preventive Vaccines Price by Player (2017-2022)
Table Preventive Vaccines Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Preventive Vaccines Sales Volume, Region Wise (2017-2022)
Table Global Preventive Vaccines Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Preventive Vaccines Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Preventive Vaccines Sales Volume Market Share, Region Wise in 2021
Table Global Preventive Vaccines Revenue (Million USD), Region Wise (2017-2022)
Table Global Preventive Vaccines Revenue Market Share, Region Wise (2017-2022)
Figure Global Preventive Vaccines Revenue Market Share, Region Wise (2017-2022)
Figure Global Preventive Vaccines Revenue Market Share, Region Wise in 2021
Table Global Preventive Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Preventive Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Preventive Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Preventive Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Preventive Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Preventive Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Preventive Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Preventive Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Preventive Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Preventive Vaccines Sales Volume by Type (2017-2022)
Table Global Preventive Vaccines Sales Volume Market Share by Type (2017-2022)
Figure Global Preventive Vaccines Sales Volume Market Share by Type in 2021
Table Global Preventive Vaccines Revenue (Million USD) by Type (2017-2022)
Table Global Preventive Vaccines Revenue Market Share by Type (2017-2022)
Figure Global Preventive Vaccines Revenue Market Share by Type in 2021
Table Preventive Vaccines Price by Type (2017-2022)
Figure Global Preventive Vaccines Sales Volume and Growth Rate of Live/Attenuated Vaccines (2017-2022)
Figure Global Preventive Vaccines Revenue (Million USD) and Growth Rate of Live/Attenuated Vaccines (2017-2022)
Figure Global Preventive Vaccines Sales Volume and Growth Rate of Inactivated Vaccines (2017-2022)
Figure Global Preventive Vaccines Revenue (Million USD) and Growth Rate of Inactivated Vaccines (2017-2022)
Figure Global Preventive Vaccines Sales Volume and Growth Rate of Subunit Vaccines (2017-2022)
Figure Global Preventive Vaccines Revenue (Million USD) and Growth Rate of Subunit Vaccines (2017-2022)
Figure Global Preventive Vaccines Sales Volume and Growth Rate of Toxoid Vaccines (2017-2022)
Figure Global Preventive Vaccines Revenue (Million USD) and Growth Rate of Toxoid Vaccines (2017-2022)
Figure Global Preventive Vaccines Sales Volume and Growth Rate of Conjugate Vaccines (2017-2022)
Figure Global Preventive Vaccines Revenue (Million USD) and Growth Rate of Conjugate Vaccines (2017-2022)
Figure Global Preventive Vaccines Sales Volume and Growth Rate of Recombinant Vector Vaccines (2017-2022)
Figure Global Preventive Vaccines Revenue (Million USD) and Growth Rate of Recombinant Vector Vaccines (2017-2022)
Figure Global Preventive Vaccines Sales Volume and Growth Rate of Other Vaccines (2017-2022)
Figure Global Preventive Vaccines Revenue (Million USD) and Growth Rate of Other Vaccines (2017-2022)
Table Global Preventive Vaccines Consumption by Application (2017-2022)
Table Global Preventive Vaccines Consumption Market Share by Application (2017-2022)
Table Global Preventive Vaccines Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Preventive Vaccines Consumption Revenue Market Share by Application (2017-2022)
Table Global Preventive Vaccines Consumption and Growth Rate of Pneumococcal Disease (2017-2022)
Table Global Preventive Vaccines Consumption and Growth Rate of Poliovirus (2017-2022)
Table Global Preventive Vaccines Consumption and Growth Rate of Hepatitis (2017-2022)
Table Global Preventive Vaccines Consumption and Growth Rate of Influenza (2017-2022)
Table Global Preventive Vaccines Consumption and Growth Rate of Measles, Mumps, and Rubella (MMR) (2017-2022)
Table Global Preventive Vaccines Consumption and Growth Rate of Varicella (2017-2022)
Table Global Preventive Vaccines Consumption and Growth Rate of Human Papilloma Virus (2017-2022)
Table Global Preventive Vaccines Consumption and Growth Rate of COVID-19 (2017-2022)
Table Global Preventive Vaccines Consumption and Growth Rate of Other Diseases (2017-2022)
Figure Global Preventive Vaccines Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Preventive Vaccines Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Preventive Vaccines Price and Trend Forecast (2022-2027)
Figure USA Preventive Vaccines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Preventive Vaccines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Preventive Vaccines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Preventive Vaccines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Preventive Vaccines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Preventive Vaccines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Preventive Vaccines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Preventive Vaccines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Preventive Vaccines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Preventive Vaccines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Preventive Vaccines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Preventive Vaccines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Preventive Vaccines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Preventive Vaccines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Preventive Vaccines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Preventive Vaccines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Preventive Vaccines Market Sales Volume Forecast, by Type
Table Global Preventive Vaccines Sales Volume Market Share Forecast, by Type
Table Global Preventive Vaccines Market Revenue (Million USD) Forecast, by Type
Table Global Preventive Vaccines Revenue Market Share Forecast, by Type
Table Global Preventive Vaccines Price Forecast, by Type
Figure Global Preventive Vaccines Revenue (Million USD) and Growth Rate of Live/Attenuated Vaccines (2022-2027)
Figure Global Preventive Vaccines Revenue (Million USD) and Growth Rate of Live/Attenuated Vaccines (2022-2027)
Figure Global Preventive Vaccines Revenue (Million USD) and Growth Rate of Inactivated Vaccines (2022-2027)
Figure Global Preventive Vaccines Revenue (Million USD) and Growth Rate of Inactivated Vaccines (2022-2027)
Figure Global Preventive Vaccines Revenue (Million USD) and Growth Rate of Subunit Vaccines (2022-2027)
Figure Global Preventive Vaccines Revenue (Million USD) and Growth Rate of Subunit Vaccines (2022-2027)
Figure Global Preventive Vaccines Revenue (Million USD) and Growth Rate of Toxoid Vaccines (2022-2027)
Figure Global Preventive Vaccines Revenue (Million USD) and Growth Rate of Toxoid Vaccines (2022-2027)
Figure Global Preventive Vaccines Revenue (Million USD) and Growth Rate of Conjugate Vaccines (2022-2027)
Figure Global Preventive Vaccines Revenue (Million USD) and Growth Rate of Conjugate Vaccines (2022-2027)
Figure Global Preventive Vaccines Revenue (Million USD) and Growth Rate of Recombinant Vector Vaccines (2022-2027)
Figure Global Preventive Vaccines Revenue (Million USD) and Growth Rate of Recombinant Vector Vaccines (2022-2027)
Figure Global Preventive Vaccines Revenue (Million USD) and Growth Rate of Other Vaccines (2022-2027)
Figure Global Preventive Vaccines Revenue (Million USD) and Growth Rate of Other Vaccines (2022-2027)
Table Global Preventive Vaccines Market Consumption Forecast, by Application
Table Global Preventive Vaccines Consumption Market Share Forecast, by Application
Table Global Preventive Vaccines Market Revenue (Million USD) Forecast, by Application
Table Global Preventive Vaccines Revenue Market Share Forecast, by Application
Figure Global Preventive Vaccines Consumption Value (Million USD) and Growth Rate of Pneumococcal Disease (2022-2027)
Figure Global Preventive Vaccines Consumption Value (Million USD) and Growth Rate of Poliovirus (2022-2027)
Figure Global Preventive Vaccines Consumption Value (Million USD) and Growth Rate of Hepatitis (2022-2027)
Figure Global Preventive Vaccines Consumption Value (Million USD) and Growth Rate of Influenza (2022-2027)
Figure Global Preventive Vaccines Consumption Value (Million USD) and Growth Rate of Measles, Mumps, and Rubella (MMR) (2022-2027)
Figure Global Preventive Vaccines Consumption Value (Million USD) and Growth Rate of Varicella (2022-2027)
Figure Global Preventive Vaccines Consumption Value (Million USD) and Growth Rate of Human Papilloma Virus (2022-2027)
Figure Global Preventive Vaccines Consumption Value (Million USD) and Growth Rate of COVID-19 (2022-2027)
Figure Global Preventive Vaccines Consumption Value (Million USD) and Growth Rate of Other Diseases (2022-2027)
Figure Preventive Vaccines Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Emergent BioSolutions Inc. Profile
Table Emergent BioSolutions Inc. Preventive Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Emergent BioSolutions Inc. Preventive Vaccines Sales Volume and Growth Rate
Figure Emergent BioSolutions Inc. Revenue (Million USD) Market Share 2017-2022
Table Merck & Co. Profile
Table Merck & Co. Preventive Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Merck & Co. Preventive Vaccines Sales Volume and Growth Rate
Figure Merck & Co. Revenue (Million USD) Market Share 2017-2022
Table Moderna Inc. Profile
Table Moderna Inc. Preventive Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Moderna Inc. Preventive Vaccines Sales Volume and Growth Rate
Figure Moderna Inc. Revenue (Million USD) Market Share 2017-2022
Table Daiichi Sankyo Co. Ltd Profile
Table Daiichi Sankyo Co. Ltd Preventive Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Daiichi Sankyo Co. Ltd Preventive Vaccines Sales Volume and Growth Rate
Figure Daiichi Sankyo Co. Ltd Revenue (Million USD) Market Share 2017-2022
Table Sanofi SA Profile
Table Sanofi SA Preventive Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Sanofi SA Preventive Vaccines Sales Volume and Growth Rate
Figure Sanofi SA Revenue (Million USD) Market Share 2017-2022
Table Johnson & Johnson Profile
Table Johnson & Johnson Preventive Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Johnson & Johnson Preventive Vaccines Sales Volume and Growth Rate
Figure Johnson & Johnson Revenue (Million USD) Market Share 2017-2022
Table Novavax, Inc. Profile
Table Novavax, Inc. Preventive Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Novavax, Inc. Preventive Vaccines Sales Volume and Growth Rate
Figure Novavax, Inc. Revenue (Million USD) Market Share 2017-2022
Table GlaxoSmithKline plc Profile
Table GlaxoSmithKline plc Preventive Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure GlaxoSmithKline plc Preventive Vaccines Sales Volume and Growth Rate
Figure GlaxoSmithKline plc Revenue (Million USD) Market Share 2017-2022
Table China National Biotec Group Company Ltd. Profile
Table China National Biotec Group Company Ltd. Preventive Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure China National Biotec Group Company Ltd. Preventive Vaccines Sales Volume and Growth Rate
Figure China National Biotec Group Company Ltd. Revenue (Million USD) Market Share 2017-2022
Table AstraZeneca plc Profile
Table AstraZeneca plc Preventive Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure AstraZeneca plc Preventive Vaccines Sales Volume and Growth Rate
Figure AstraZeneca plc Revenue (Million USD) Market Share 2017-2022
Table CSL Ltd. Profile
Table CSL Ltd. Preventive Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure CSL Ltd. Preventive Vaccines Sales Volume and Growth Rate
Figure CSL Ltd. Revenue (Million USD) Market Share 2017-2022
Table Takeda Pharmaceutical Co. Ltd. Profile
Table Takeda Pharmaceutical Co. Ltd. Preventive Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Takeda Pharmaceutical Co. Ltd. Preventive Vaccines Sales Volume and Growth Rate
Figure Takeda Pharmaceutical Co. Ltd. Revenue (Million USD) Market Share 2017-2022
Table Bavarian Nordic A/S Profile
Table Bavarian Nordic A/S Preventive Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Bavarian Nordic A/S Preventive Vaccines Sales Volume and Growth Rate
Figure Bavarian Nordic A/S Revenue (Million USD) Market Share 2017-2022
Table Pfizer Inc. Profile
Table Pfizer Inc. Preventive Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pfizer Inc. Preventive Vaccines Sales Volume and Growth Rate
Figure Pfizer Inc. Revenue (Million USD) Market Share 2017-2022
